Expression of CCL2 is significantly different in five breast cancer genotypes and predicts patient outcome.
about
SUSD2 promotes tumor-associated macrophage recruitment by increasing levels of MCP-1 in breast cancer.The Yin/Yan of CCL2: a minor role in neutrophil anti-tumor activity in vitro but a major role on the outgrowth of metastatic breast cancer lesions in the lung in vivo.Data report on inflammatory C-C chemokines among insulin-using women with diabetes mellitus and breast cancer.Insulin secretagogue use and circulating inflammatory C-C chemokine levels in breast cancer patients.MCP-1 is overexpressed in triple-negative breast cancers and drives cancer invasiveness and metastasis.
P2860
Expression of CCL2 is significantly different in five breast cancer genotypes and predicts patient outcome.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Expression of CCL2 is signific ...... and predicts patient outcome.
@ast
Expression of CCL2 is signific ...... and predicts patient outcome.
@en
type
label
Expression of CCL2 is signific ...... and predicts patient outcome.
@ast
Expression of CCL2 is signific ...... and predicts patient outcome.
@en
prefLabel
Expression of CCL2 is signific ...... and predicts patient outcome.
@ast
Expression of CCL2 is signific ...... and predicts patient outcome.
@en
P2093
P2860
P1476
Expression of CCL2 is signific ...... and predicts patient outcome.
@en
P2093
Sheng-Fu Xu
Yu-Guo Shao
Zhi-Gang Zhuang
P2860
P304
15684-15691
P577
2015-09-15T00:00:00Z